Eptacog alfa pegol (activated) Completed Phase 2 Trials for Haemophilia A With Inhibitors / Haemophilia B With Inhibitors / Congenital Hematological Disorder Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT00951405Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors